Davis LS - Search Results

1

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1.

Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE. Kavanaugh AF, et al. Among authors: davis ls. Arthritis Rheum. 1994 Jul;37(7):992-9. doi: 10.1002/art.1780370703. Arthritis Rheum. 1994. PMID: 7912930 Clinical Trial.

2

Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules.

Jasin HE, Lightfoot E, Davis LS, Rothlein R, Faanes RB, Lipsky PE. Jasin HE, et al. Among authors: davis ls. Arthritis Rheum. 1992 May;35(5):541-9. doi: 10.1002/art.1780350508. Arthritis Rheum. 1992. PMID: 1374251

3

Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation.

Thomas R, McIlraith M, Davis LS, Lipsky PE. Thomas R, et al. Among authors: davis ls. Arthritis Rheum. 1992 Dec;35(12):1455-65. doi: 10.1002/art.1780351209. Arthritis Rheum. 1992. PMID: 1472123

4

Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness.

Tao X, Davis LS, Lipsky PE. Tao X, et al. Among authors: davis ls. Arthritis Rheum. 1991 Oct;34(10):1274-81. doi: 10.1002/art.1780341011. Arthritis Rheum. 1991. PMID: 1930317

5

Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit.

Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Schulze-Koops H, et al. Among authors: davis ls. J Immunol. 1995 Nov 15;155(10):5029-37. J Immunol. 1995. PMID: 7594511

6

Elevated interleukin-10 levels in patients with rheumatoid arthritis.

Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE. Cush JJ, et al. Among authors: davis ls. Arthritis Rheum. 1995 Jan;38(1):96-104. doi: 10.1002/art.1780380115. Arthritis Rheum. 1995. PMID: 7818579

7

Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis.

Davis LS, Kavanaugh AF, Nichols LA, Lipsky PE. Davis LS, et al. J Immunol. 1995 Apr 1;154(7):3525-37. J Immunol. 1995. PMID: 7897232

8

A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis.

Kavanaugh AF, Davis LS, Jain RI, Nichols LA, Norris SH, Lipsky PE. Kavanaugh AF, et al. Among authors: davis ls. J Rheumatol. 1996 Aug;23(8):1338-44. J Rheumatol. 1996. PMID: 8856611 Clinical Trial.

9

Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1).

Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Schulze-Koops H, et al. Among authors: davis ls. Clin Exp Immunol. 1996 Nov;106(2):190-6. doi: 10.1046/j.1365-2249.1996.d01-828.x. Clin Exp Immunol. 1996. PMID: 8918562 Free PMC article.

10

Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activation.

Schulze-Koops H, Davis LS, Kavanaugh AF, Lipsky PE. Schulze-Koops H, et al. Among authors: davis ls. Arthritis Rheum. 1997 Apr;40(4):639-47. doi: 10.1002/art.1780400408. Arthritis Rheum. 1997. PMID: 9125245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters